InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kaufmann Gunnar F., Directeur Scientifique. Officer active across 1 company, notably Oncternal Therapeutics, Inc.. Cumulatively, 4 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 12 June 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kaufmann Gunnar F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
25,000 shares@ US$0.349857.6% of flowCommon StockSEC:0001209191-23-036994:0
Canonical exit: 10 Sept 2023 (T+90)
6,266 shares@ US$1.0242.4% of flowCommon StockSEC:0001209191-23-002030:0
43,125 shares0Common StockSEC:0001209191-22-043738:0
29,867 shares0Common StockSEC:0001209191-22-001972:0
4 of 4 declarations
About Kaufmann Gunnar F.
Gunnar F. Kaufmann is the Chief Scientific Officer at Oncternal Therapeutics, Inc. In this role, he oversees the company's research and development activities. His scientific expertise is essential to guide research initiatives and ensure innovation.
